Drug intelligence / Profile preview

proximicin C

Development stage
Preclinical
Lead developer
UCL School of Pharmacy
Modality
Peptides, Small Molecules
Administration
Intravenous
01

Overview

Proximicin C is a furan-based oligopeptide antibiotic and antitumor agent originally isolated from marine actinomycetes of the genus *Verrucosispora*. It is structurally characterized by the presence of the unusual amino acid 4-aminofuran-2-carboxylic acid and shares structural similarities with the DNA-binding agents distamycin and netropsin. Proximicin C exhibits significant cytotoxicity against various cancer cell lines, including gastric adenocarcinoma, glioblastoma (U-87 MG), and breast carcinoma (MDA-MD-231). Its mechanism of action involves binding to DNA and inducing the up-regulation of p53 and p21, leading to cell-cycle arrest at the G1/S transition and subsequent apoptosis. Research into proximicin C has demonstrated its potential as a synthetic target for the development of broad-utility anticancer drugs.

02

Targets

CDKN1A (Cyclin-dependent kinase inhibitor 1A)TP53 (Cellular Tumor Antigen p53 R175H)DNA

Beyond the preview

Go deeper on proximicin C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proximicin C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call